Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.14 by 21.43 percent. This is a 32 percent decrease over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $157.21 million which missed the analyst consensus estimate of $177.94 million by 11.65 percent. This is a 7.09 percent increase over sales of $146.81 million the same period last year.